1) Drobyski WR, Knox KK, Majewski D, et al. Brief report: fatal encephalitis due to variant B human herpesvirus-6 infection in a bone marrow-transplant recipient. N Engl J Med. 1994; 330: 1356-60
|
|
|
2) Zerr DM, Corey L, Kim HW, et al. Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation. Clin Infect Dis. 2005; 40: 932-40
|
|
|
3) Ogata M, Kikuchi H, Satou T, et al. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance. J Infect Dis. 2006; 193: 68-79
|
|
|
4) Yamane A, Mori T, Suzuki S, et al. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders. Biol Blood Marrow Transplant. 2007; 13: 100-6
|
|
|
5) Ogata M, Satou T, Kawano R, et al. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation. Bone Marrow Transplant. 2008; 41: 279-85
|
|
|
6) 加登大介, 小泉優子, 高木伸介, 他. 臍帯血移植後のHHV6辺縁系脳炎 [抄録]. 臨床血液. 2006; 47: 181
|
|
|
7) Fukuda T, Fujimaki K, Taniguchi S, et al. Retrospective analysis of 23 cases with human herpesvirus-6 associated encephalitis after allogeneic hematopoietic cell transplantation [abstract]. Blood. 2004; 104: 350b
|
|
|
8) Zerr DM. Human herpesvirus 6 and central nervous system disease in hematopoietic cell transplantation. J Clin Virol. 2006; 37: 52-6
|
|
|
9) Seeley WW, Marty FM, Holmes TM, et al. Post-transplant acute limbic encephalitis: clinical features and relationship to HHV-6. Neurology. 2007; 69: 156-65
|
|
|
10) Fotheringham J, Williams EL, Akhyani N, et al. Human herpesvirus 6 (HHV-6) induced dysregulation of glutamate uptake and transporter expression in astrocytes. J Neuroimmune Pharmacol. 2008; 3: 105-16
|
|
|
11) Rogers J, Rohal S, Carrigan DR, et al. Human herpesvirus-6 in liver transplant recipients: role in pathogenesis of fungal infections, neurologic complications, and outcome. Transplantation. 2000; 69: 2566-73
|
|
|
12) 伊東貴雄, 大石知瑞子, 千葉厚郎, 他. フェノバルビタールによるdrug-induced hypersensitivity syndromeに続発した辺縁系脳炎の1例. 臨床神経学. 2005; 45: 495-501
|
|
|
13) Astriti M, Zeller V, Boutolleau D, et al. Fatal HHV-6 associated encephalitis in an HIV-1 infected patient treated with cidofovir. J Infect. 2006; 52: 237-42
|
|
|
14) 井筒挙策, 安部康信, 乙成 淳, 他. ヒトヘルペスウイルス6型脳炎を合併した成人T細胞白血病/リンパ腫. 臨床血液. 2007; 48: 664-6
|
|
|
15) Suga S, Yoshikawa T, Asano Y, et al. Clinical and virological analysis of 21 infants with exanthem subitum (roseola infantum) and central nervous system complications. Ann Neurol. 1993; 33: 597-603
|
|
|
16) 大橋正博, 吉川哲史, 三宅 史, 他. 突発疹関連脳炎脳症の全国調査. 小児感染免疫. 2006; 18: 385-92
|
|
|
17) Birnbaum T, Padovan CS, Sporer B, et al. Severe meningoencephalitis caused by human herpesvirus type B in an immunocompetent woman treated with ganciclovir. Clin Infect Dis. 2005; 40: 887-9
|
|
|
18) Issacson E, Glaser CA, Forghani B, et al. Evidence of human herpesvirus 6 infection in 4 immunocompetent patients with encephalitis. Clin Infect Dis. 2005; 40: 890-3
|
|
|
19) Whitely RJ, Lakeman FD. Human herpesvirus 6 infection of the central nervous system: is it just a case of mistaken association? Clin Infect Dis. 2005; 40: 894-5
|
|
|
20) Fotheringham J, Donati D, Akhyani N, et al. Association of human herpesvirus-6B with mesial temporal lobe epilepsy. PLoS Med. 2007: 4: e180
|
|
|
21) Niebuhr DW, Millikan AM, Yolken R, et al. Results from a hypothesis fenerating case-control study: Herpes family viruses and shizophrenia among military personnel. Shizophr Bull. 2008; 34: 1182-8
|
|
|
22) Zerr DM, Meier AS, Selke SS, et al. A population-based study of primary human herpesvirus 6 infection. N Engl J Med. 2005; 352: 768-76
|
|
|
23) Derfuss T, Hohlfeld R, Meinl E. Intrathecal antibody (IgG) production against human herpesvirus type 6 occurs in about 20% of multiple sclerosis patients and might be linked to a polyspecific B-cell response. J Neurol. 2005; 252: 968-71
|
|
|
24) Komaroff AL. Is human herpesvirus-6 a trigger for chronic fatigue syndrome? J Clin Virol. 2006; 37: S39-46
|
|
|
25) Zerr DM. Human herpesvirus 6: a clinical update. Herpes. 2006; 13: 20-4
|
|
|
26) Tomoiu A, Flamand L. Biological and clinical advances in human herpesvirus-6 and -7 research. Future Virol. 2006; 1: 623-35
|
|
|
27) Reddy S, Manna P. Quantitative detection and differentiation of human herpesvirus 6 subtypes in bone marrow transplant patients by using a single real-time polymerase chain reaction assay. Biol Blood Marrow Transplant. 2005; 11: 530-41
|
|
|
28) Hentrich M, Oruzio D, Jager G, et al. Impact of human herpesvirus-6 after haematopoietic stem cell transplantation. Br J Haematol. 2005; 128: 66-72
|
|
|
29) Sashihara J, Tanaka-Taya K, Tanaka S, et al. High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood. 2002; 100: 2005-11
|
|
|
30) Fotheringham J, Akhyani N, Vortmeyer A, et al. Detection of active human herpesvirus-6 infection in the brain: correlation with polymerase chain reaction detection in cerebrospinal fluid. J Infect Dis. 2007; 195: 450-4
|
|
|
31) Wainwright MS, Martin PL, Morse RP, et al. Human herpesvirus 6 limbic encephalitis after stem cell transplantation. Ann Neurol. 2001; 50: 612-9
|
|
|
32) Ljungman P, Wang FZ, Clark DA, et al. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients. Br J Haematol. 2000; 111: 774-81
|
|
|
33) Fujimaki K, Mori T, Kida A, et al. Human herpesvirus 6 meningoencephalitis in allogeneic hematopoietic stem cell transplant recipients. Int J Hematol. 2006; 84: 432-7
|
|
|
34) Vu T, Carrum G, Hutton G, et al. Human herpesvirus-6 encephalitis following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2007; 39: 705-9
|
|
|
35) Ogata M, Ikewaki J, Kohno K, et al. Human herpesvirus 6 reactivation in patients with adult T Cell leukemia [abstract]. AIDS Res Hum Retroviruses. 2007; 23: 603
|
|
|
36) Bossolasco S, Marenzi R, Dahl H, et al. Human herpesvirus 6 in cerebrospinal fluid of patients infected with HIV: frequency and clinical significance. J Neurol Neurosurg Psychiatry. 1999; 67: 789-92
|
|
|
37) 緒方正男, 佐藤隆子, 高倉俊一, 他. HHV-6脳炎の発症と全身性サイトカイン反応との関連 [抄録]. 第30回日本造血細胞移植学会総会プログラム抄録集. 2008. p. 170
|
|
|
38) Wang FZ, Linde A, Hagglund H, et al. Human herpesvirus 6 DNA in cerebrospinal fluid specimens from allogeneic bone marrow transplant patients: does it have clinical significance? Clin Infect Dis. 1999; 28: 562-8
|
|
|
39) Zerr DM, Gupta D, Huang ML, et al. Effect of antivirals on human herpesvirus 6 replication in hematopoietic stem cell transplant recipients. Clin Infect Dis. 2002; 34: 309-17
|
|
|
40) Flamand L, Gravel A, Boutolleau D, et al. Multicenter comparison of PCR assays for the detection of human herpesvirus 6 DNA in serum. J Clin Microbiol. 2008; 46: 2700-6
|
|
|
41) Noguchi T, Mihara F, Yoshiura T, et al. MR imaging of human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation in adults. AJNR Am J Neuroradiol. 2006; 27: 2191-5
|
|
|
42) Takaya J, Araki A, Mori K, et al. Usefulness of diffusion-weighted MRI in human herpesvirus-6 encephalitis. Acta Paediatr. 2007; 96: 137-8
|
|
|
43) Dewhurst S. Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes. 2004; 11: 105A-111A
|
|
|
44) Pohlmann C, Schetelig J, Reuner U, et al. Cidofovir and foscarnet for treatment of human herpesvirus 6 encephalitis in a neutropenic stem cell transplant recipient. Clin Infect Dis. 2007; 44: 118-20
|
|
|
45) Rapaport D, Engelhard D, Tagger G, et al. Antiviral prophylaxis may prevent human herpesvirus-6 reactivation in bone marrow transplant recipients. Transpl Infect Dis. 2002; 4: 10-6
|
|
|
46) Tokimasa S, Hara J, Osugi Y, et al. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation. Bone Marrow Transplant. 2002; 29: 595-8
|
|
|
47) Razonable RR, Brown RA, Humar A, et al. Herpesvirus infections in solid organ transplant patients at high risk of primary cytomegalovirus disease. J Infect Dis. 2005; 192: 1331-9
|
|
|
48) Ljungman P, de la Camara R, Cordonnier C, et al. Management of CMV, HHV-6, HHV-7 and Kaposi-sarcome herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT. Bone Marrow Transplant. 2008; 42: 227-40
|
|
|